FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2607177890> ?p ?o ?g. }

• W2607177890 endingPage "53" @default.
• W2607177890 startingPage "43" @default.
• W2607177890 abstract "Activation of Nrf2 with sulforaphane has recently gained attention as a new therapeutic approach in the treatment of many diseases, including epilepsy. As a plant-derived compound, sulforaphane is considered to be safe and well-tolerated. It is widely consumed, also by patients suffering from seizure and taking antiepileptic drugs, but no toxicity profile of sulforaphane exists. Since many natural remedies and dietary supplements may increase seizure risk and potentially interact with antiepileptic drugs, the aim of our study was to investigate the acute effects of sulforaphane on seizure thresholds and activity of some first- and second-generation antiepileptic drugs in mice. In addition, some preliminary toxicity profile of sulforaphane in mice after intraperitoneal injection was evaluated. The LD50 value of sulforaphane in mice was estimated at 212.67 mg/kg, while the TD50 value – at 191.58 mg/kg. In seizure tests, sulforaphane at the highest dose tested (200 mg/kg) significantly decreased the thresholds for the onset of the first myoclonic twitch and generalized clonic seizure in the iv PTZ test as well as the threshold for the 6 Hz-induced psychomotor seizure. At doses of 10–200 mg/kg, sulforaphane did not affect the threshold for the iv PTZ-induced forelimb tonus or the threshold for maximal electroshock-induced hindlimb tonus. Interestingly, sulforaphane (at 100 mg/kg) potentiated the anticonvulsant efficacy of carbamazepine in the maximal electroshock seizure test. This interaction could have been pharmacokinetic in nature, as sulforaphane increased concentrations of carbamazepine in both serum and brain tissue. The toxicity study showed that high doses of sulforaphane produced marked sedation (at 150–300 mg/kg), hypothermia (at 150–300 mg/kg), impairment of motor coordination (at 200–300 mg/kg), decrease in skeletal muscle strength (at 250–300 mg/kg), and deaths (at 200–300 mg/kg). Moreover, blood analysis showed leucopenia in mice injected with sulforaphane at 200 mg/kg. In conclusion, since sulforaphane was proconvulsant at a toxic dose, the safety profile and the risk-to-benefit ratio of sulforaphane usage in epileptic patients should be further evaluated." @default.
• W2607177890 created "2017-04-28" @default.
• W2607177890 creator A5011986370 @default.
• W2607177890 creator A5034537296 @default.
• W2607177890 creator A5036187783 @default.
• W2607177890 creator A5047884679 @default.
• W2607177890 creator A5073818963 @default.
• W2607177890 date "2017-07-01" @default.
• W2607177890 modified "2023-10-01" @default.
• W2607177890 title "Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice" @default.
• W2607177890 cites W1231316025 @default.
• W2607177890 cites W1482023004 @default.
• W2607177890 cites W1487878063 @default.
• W2607177890 cites W1516709032 @default.
• W2607177890 cites W1583707695 @default.
• W2607177890 cites W1925884394 @default.
• W2607177890 cites W1971573216 @default.
• W2607177890 cites W1972532680 @default.
• W2607177890 cites W1976266172 @default.
• W2607177890 cites W1976768416 @default.
• W2607177890 cites W1986099314 @default.
• W2607177890 cites W1986685890 @default.
• W2607177890 cites W1997220879 @default.
• W2607177890 cites W2019810831 @default.
• W2607177890 cites W2022786081 @default.
• W2607177890 cites W2025450822 @default.
• W2607177890 cites W2027456968 @default.
• W2607177890 cites W2049230929 @default.
• W2607177890 cites W2053488505 @default.
• W2607177890 cites W2053821985 @default.
• W2607177890 cites W2063637433 @default.
• W2607177890 cites W2063831487 @default.
• W2607177890 cites W2065239004 @default.
• W2607177890 cites W2068078405 @default.
• W2607177890 cites W2074764860 @default.
• W2607177890 cites W2083672753 @default.
• W2607177890 cites W2091503341 @default.
• W2607177890 cites W2101283650 @default.
• W2607177890 cites W2103863911 @default.
• W2607177890 cites W2105455720 @default.
• W2607177890 cites W2122641630 @default.
• W2607177890 cites W2133772979 @default.
• W2607177890 cites W2134877431 @default.
• W2607177890 cites W2139956257 @default.
• W2607177890 cites W2142266221 @default.
• W2607177890 cites W2167250040 @default.
• W2607177890 cites W2207884387 @default.
• W2607177890 cites W2231946053 @default.
• W2607177890 cites W2302141966 @default.
• W2607177890 cites W2569380901 @default.
• W2607177890 doi "https://doi.org/10.1016/j.taap.2017.04.010" @default.
• W2607177890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28412310" @default.
• W2607177890 hasPublicationYear "2017" @default.
• W2607177890 type Work @default.
• W2607177890 sameAs 2607177890 @default.
• W2607177890 citedByCount "33" @default.
• W2607177890 countsByYear W26071778902017 @default.
• W2607177890 countsByYear W26071778902018 @default.
• W2607177890 countsByYear W26071778902019 @default.
• W2607177890 countsByYear W26071778902020 @default.
• W2607177890 countsByYear W26071778902021 @default.
• W2607177890 countsByYear W26071778902022 @default.
• W2607177890 countsByYear W26071778902023 @default.
• W2607177890 crossrefType "journal-article" @default.
• W2607177890 hasAuthorship W2607177890A5011986370 @default.
• W2607177890 hasAuthorship W2607177890A5034537296 @default.
• W2607177890 hasAuthorship W2607177890A5036187783 @default.
• W2607177890 hasAuthorship W2607177890A5047884679 @default.
• W2607177890 hasAuthorship W2607177890A5073818963 @default.
• W2607177890 hasConcept C116263406 @default.
• W2607177890 hasConcept C118552586 @default.
• W2607177890 hasConcept C126322002 @default.
• W2607177890 hasConcept C185592680 @default.
• W2607177890 hasConcept C2775858608 @default.
• W2607177890 hasConcept C2777010014 @default.
• W2607177890 hasConcept C2778186239 @default.
• W2607177890 hasConcept C2778460930 @default.
• W2607177890 hasConcept C2779253243 @default.
• W2607177890 hasConcept C2780841255 @default.
• W2607177890 hasConcept C29730261 @default.
• W2607177890 hasConcept C42219234 @default.
• W2607177890 hasConcept C55493867 @default.
• W2607177890 hasConcept C71924100 @default.
• W2607177890 hasConcept C98274493 @default.
• W2607177890 hasConceptScore W2607177890C116263406 @default.
• W2607177890 hasConceptScore W2607177890C118552586 @default.
• W2607177890 hasConceptScore W2607177890C126322002 @default.
• W2607177890 hasConceptScore W2607177890C185592680 @default.
• W2607177890 hasConceptScore W2607177890C2775858608 @default.
• W2607177890 hasConceptScore W2607177890C2777010014 @default.
• W2607177890 hasConceptScore W2607177890C2778186239 @default.
• W2607177890 hasConceptScore W2607177890C2778460930 @default.
• W2607177890 hasConceptScore W2607177890C2779253243 @default.
• W2607177890 hasConceptScore W2607177890C2780841255 @default.
• W2607177890 hasConceptScore W2607177890C29730261 @default.
• W2607177890 hasConceptScore W2607177890C42219234 @default.
• W2607177890 hasConceptScore W2607177890C55493867 @default.
• W2607177890 hasConceptScore W2607177890C71924100 @default.

• next